Novartis ‘game changer’ heart shot MIA
By Megan Brodie 2 years ago | In Cell and gene therapies, Companies, Products, Regulatory- 2 years ago
17 September 2021 Novartis’ new anti-cholesterol injection LEQVIO (inclisiran) has been registered by the TGA…
This is subscriber-only content. Please login to continue reading.